Alembic Pharmaceuticals Outperforms Sector Amid Broader Market Decline and Volatility

Alembic Pharmaceuticals has shown significant activity today, with a notable gain of 7.25% on March 4, 2025. This performance has allowed the stock to outperform its sector by 4.14%. Over the past two days, Alembic has experienced consecutive gains, accumulating a total return of 4.78%. The stock reached an intraday high of Rs 789, reflecting a 4.7% increase, while the day's low was recorded at Rs 733.2, marking a decline of 2.7%.
In the broader market context, the Sensex opened lower at 72,817.34, down 268.60 points, and is currently trading at 72,964.02. The index is nearing its 52-week low and has been on a bearish trend, trading below its 50-day moving average. Despite the overall market challenges, Alembic Pharmaceuticals has managed to deliver a 1.40% gain over the past week, contrasting with the Sensex's decline of 2.18%. However, the stock's performance over the longer term remains under pressure, with a year-to-date decline of 24.18%.